Soluble uPAR/CD87 is a biomarker for pneumonia, sepsis, kidney injury and cardiovascular research.
Hayek S.S. and Dryer S.E. uPAR/suPAR Signaling and Organ Crosstalk in Cardiovascular-Kidney-Metabolic Syndrome.Circ Res. 2026 Jun 19;139(1):e328563
Circulating urokinase receptor as a cause of focal segmental glomerulosclerosis. Wei C et al. Nat Med. 2011 Jul 31;17(8):952-60.
Urine But Not Serum Soluble Urokinase Receptor (suPAR) May Identify Cases of Recurrent FSGS in Kidney Transplant Candidates. Carlos R Franco Palacios, et al.Transplantation. 2013 Aug 27; 96(4): 394–399.
